Fig. 2. Receiver operating characteristic curve analysis of the serum protein levels before administration of the second-line intravenous immunoglobulin treatment to determine predictors of unresponsiveness.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.